Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Sino Medical Sciences Technology Inc.
  6. News
  7. Summary
    688108   CNE100003NY2

SINO MEDICAL SCIENCES TECHNOLOGY INC.

(688108)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

SINOMED Announces the First Commercial Implantation and European Launch of the HT Supreme Drug Eluting Stent

08/17/2021 | 06:00am EDT

SINOMED announced the first commercial implantation of the HT Supreme Drug-Eluting Stent at University Hospital Galway in partnership with the National University of Ireland Galway marking the start of the European launch. The procedure was successfully performed by Professor Faisal Sharif, Professor of Translational Cardiovascular Medicine and Innovation at NUI Galway and Consultant Interventional Cardiologist at Galway University Hospitals.


© S&P Capital IQ 2021
All news about SINO MEDICAL SCIENCES TECHNOLOGY INC.
08/24Sino Medical Sciences Technology Inc. Reports Earnings Results for the Half Year Ended ..
CI
08/17SINOMED Announces the First Commercial Implantation and European Launch of the HT Supre..
CI
07/05SINOMED Announces Clinical Collaboration with the National University of Ireland Galway..
CI
06/01Sino Medical's Two Shareholders Plan to Unload Stakes in the Company
CI
04/27Sino Medical Sciences Technology Inc. Reports Earnings Results for the First Quarter En..
CI
02/25Sino Medical Sciences Technology Inc. Reports Earnings Results for the Full Year Ended ..
CI
2020SINOMED Announces Late-Breaking Study Results of the Supreme HT Healing-Targeted DES De..
CI
2020Two Shareholders Plan to Cut Stakes in Sino Medical Sciences
CI
2020Sino Medical Sciences Technology Inc. Reports Earnings Results for the Second Quarter E..
CI
2020Sino Medical Sciences Technology Inc. Completes One-Year Follow-Up of the PIONEER-III E..
CI
More news
Financials
Sales 2021 - - -
Net income 2021 54,9 M 8,59 M 8,59 M
Net Debt 2021 - - -
P/E ratio 2021 88,4x
Yield 2021 -
Capitalization 3 264 M 511 M 511 M
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 522
Free-Float 34,0%
Chart SINO MEDICAL SCIENCES TECHNOLOGY INC.
Duration : Period :
Sino Medical Sciences Technology Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINO MEDICAL SCIENCES TECHNOLOGY INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 7,96 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Jian Hua Sun Chairman & General Manager
Li Hua Shen Chief Financial Officer & Director
Chang Chun Yu Independent Director
Rui Li Independent Director
Yan Gao Independent Director
Sector and Competitors